Paclitaxel in Treating Women With Recurrent Solid Tumors
Study Information
Alliance Study ID: CALGB-9763
NCT Study ID (ClinicalTrials.gov): NCT00003130
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Solid Tumors
Alliance Study Chair: Antonius A. Miller, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating women who have recurrent solid tumors.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information